Search
for
Sort by
Research 61–90 of 1000+
- Polycystic ovary syndrome
- Pathogenesis of Cardiovascular Alterations in Dogs Treated with Minoxidil
- LB1101 Evaluating the cardiovascular safety of low-dose oral minoxidil in patients with non-scarring alopecia: A retrospective cohort study
- Endocrinology of Transgender Medicine
- Cardiometabolic Risk Factors in Rosuvastatin-Treated Men with Mixed Dyslipidemia and Early-Onset Androgenic Alopecia
- Premature graying of hair
- Expanding the therapeutic landscape of minoxidil for androgenetic alopecia: topical, oral and sublingual formulations
- Progesterone in gender-affirming therapy of trans women
- From Piezoelectric Nanogenerator to Non-Invasive Medical Sensor: A Review
- Women's midlife health Reframing menopause
- Guidelines for the Use of Acitretin in Psoriasis
- Exploring Hormone Therapy Effects on Reproduction and Health in Transgender Individuals
- Low-Dose Oral Minoxidil for Alopecia: A Comprehensive Review
- Updated Integrated Safety Analysis of Ritlecitinib Up to ~5 Years in Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Antioxidants and Mitochondrial Bioenergetics
- Acne Vulgaris Associated with Polycystic Ovary Syndrome (Pcos)
- Female pattern hair loss
- Polycystic ovary syndrome in men
- Polycystic ovarian syndrome
- Adult Male Hypogonadism: A Laboratory Medicine Perspective on Its Diagnosis and Management
- Polycystic ovarian syndrome: an updated review of pathophysiology, clinical features, biomarkers, and management
- “From evidence to practice” – Insights from the multidisciplinary team on the optimal integration of GLP‐1 receptor agonists in obesity management services
- Androgenetic Alopecia in Al-Qalyubia Governorate: A Comprehensive Review
- Combination of baricitinib and conventional immunomodulating therapy for alopecia totalis
- Insulin resistance as risk factor for the development of type 2 diabetes mellitus: a systematic approach
- Minoxidil Ingestion in a Toddler
- Síndrome de ovarios poliquísticos Polycystic ovary syndrome
- DHEA : why, when, and how much ? D’après la conférence de Bruno Allolio (Wuerzburg), 50e Journées internationales d’endocrinologie clinique Henri-Pierre KLOTZ, septembre 2007
- Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
- Obesity and the Polycystic Ovary Syndrome